Xeris Biopharma Holdings, Inc.

NasdaqGS:XERS Stock Report

Market Cap: US$252.0m

Xeris Biopharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:XERS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Mar 24BuyUS$9,720John SchmidIndividual4,500US$2.16
27 Nov 23BuyUS$10,098Jeffrey ShermanIndividual5,400US$1.87
20 Nov 23BuyUS$54,600Steven PieperIndividual28,000US$1.95
20 Nov 23BuyUS$9,954Dawn HalkuffIndividual5,410US$1.84
17 Nov 23BuyUS$50,400John ShannonIndividual30,769US$1.64
16 Nov 23BuyUS$9,815John SchmidIndividual6,500US$1.51
14 Nov 23BuyUS$10,058Marla PerskyIndividual6,370US$1.58
09 Aug 23BuyUS$23,794Paul EdickIndividual10,000US$2.38

Insider Trading Volume

Insider Buying: XERS insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of XERS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies27,8480.0198%
Individual Insiders6,233,1984.44%
Institutions62,915,66944.8%
General Public71,276,75250.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8%.


Top Shareholders

Top 25 shareholders own 42.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.13%
BlackRock, Inc.
10,011,391US$18.0m6.8%no data
5.05%
The Vanguard Group, Inc.
7,086,345US$12.7m0.86%no data
4.23%
Stonepine Capital Management LLC
5,937,000US$10.7m0.37%5.03%
4.02%
Caxton Associates LP
5,641,920US$10.1m0%0.51%
2.74%
BioImpact Capital LLC
3,847,232US$6.9m-3.53%1.54%
2.52%
Rosalind Advisors, Inc.
3,543,685US$6.4m0%5.19%
2.16%
Medical Strategy GmbH, Asset Management Arm
3,028,755US$5.4m-2.46%0.32%
2.06%
Geode Capital Management, LLC
2,892,077US$5.2m4.28%no data
1.94%
State Street Global Advisors, Inc.
2,724,126US$4.9m5.99%no data
1.16%
Steven Pieper
1,626,912US$2.9m38.2%no data
1.15%
Paul Edick
1,621,494US$2.9m47.9%no data
1.1%
Millennium Management LLC
1,547,955US$2.8m-31.9%no data
0.98%
Renaissance Technologies LLC
1,381,640US$2.5m35.2%no data
0.86%
Morgan Stanley, Investment Banking and Brokerage Investments
1,205,746US$2.2m91.9%no data
0.83%
Northern Trust Global Investments
1,165,363US$2.1m1.76%no data
0.75%
D. E. Shaw & Co., L.P.
1,054,610US$1.9m20.5%no data
0.75%
Redmile Group, LLC
1,046,587US$1.9m0%0.08%
0.59%
John Shannon
825,242US$1.5m86.8%no data
0.5%
John Johnson
708,912US$1.3m43.7%no data
0.4%
Invenomic Capital Management LP
568,619US$1.0m0%0.13%
0.39%
Tudor Investment Corporation
553,411US$993.1k-13.7%0.01%
0.38%
Steven Prestrelski
536,447US$962.6k0%no data
0.37%
Columbia Management Investment Advisers, LLC
520,121US$933.3k-11.5%no data
0.35%
Beth Hecht
496,635US$891.2k199%no data
0.3%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
419,567US$752.9k-41.1%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.